Ardeypharm GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1970-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://www.ardeypharm.de
Clinical Trials
8
Active:5
Completed:3
Trial Phases
4 Phases
Phase 1:3
Phase 2:1
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (50.0%)Phase 2
1 (16.7%)Phase 3
1 (16.7%)Phase 4
1 (16.7%)E. Coli Nissle 1917 - Suspension for Infection Prophylaxis
Phase 3
Completed
- Conditions
- Infections
- Interventions
- Drug: PlaceboDrug: EcN-Suspension
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2020-10-27
- Lead Sponsor
- Ardeypharm GmbH
- Target Recruit Count
- 567
- Registration Number
- NCT02802059
- Locations
- 🇩🇪
Krankenhaus St. Elisabeth & St. Barbara, Halle (Saale), Germany
🇩🇪Universitätsklinikum Jena - Klinik für Kinder- und Jugendmedizin, Jena, Germany
🇩🇪Klinikum Westbrandenburg, Potsdam, Germany
News
No news found